ASTM F2038-2000(2011) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part IFormulations and Uncured Materials《医用硅胶弹性体 凝胶和泡沫标准指南第一部分 配方和未处理的材料》.pdf

《ASTM F2038-2000(2011) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part IFormulations and Uncured Materials《医用硅胶弹性体 凝胶和泡沫标准指南第一部分 配方和未处理的材料》.pdf》由会员分享，可在线阅读，更多相关《ASTM F2038-2000(2011) Standard Guide for Silicone Elastomers Gels and Foams Used in Medical Applications Part IFormulations and Uncured Materials《医用硅胶弹性体 凝胶和泡沫标准指南第一部分 配方和未处理的材料》.pdf（5页珍藏版）》请在麦多课文档分享上搜索。

1、Designation: F2038 00 (Reapproved 2011)Standard Guide forSilicone Elastomers, Gels, and Foams Used in MedicalApplications Part IFormulations and Uncured Materials1This standard is issued under the fixed designation F2038; the number immediately following the designation indicates the year oforiginal

2、 adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 This guide is intended to educate potential users ofsilicone elasto

3、mers, gels, and foams relative to their formula-tion and use. It does not provide information relative to siliconepowders, fluids, and other silicones. The information providedis offered to guide users in the selection of appropriatematerials, after consideration of the chemical, physical, andtoxico

4、logical properties of individual ingredients or by-products. This guide offers general information about siliconematerials typically used for medical applications. Detail on thecrosslinking and fabrication of silicone materials is found inPart II of this guide.1.2 Fabrication and properties of elast

5、omers is covered inthe companion document, F604, Part II. This monographaddresses only components of uncured elastomers, gels, andfoams.1.3 Silicone biocompatibility issues can be addressed atseveral levels, but ultimately the device manufacturer mustassess biological suitability relative to intende

6、d use.1.4 Biological and physical properties tend to be morereproducible when materials are manufactured in accordancewith accepted quality standards such as ANSI ISO 9001 andcurrent FDA Quality System Regulations/Good ManufacturingPractice Regulations.1.5 The values stated in inch-pound units are t

7、o be regardedas standard. The values given in parentheses are mathematicalconversions to SI units that are provided for information onlyand are not considered standard.1.6 This standard does not purport to address all of thesafety concerns, if any, associated with its use. It is theresponsibility of

8、 the user of this standard to establish appro-priate safety and health practices and determine the applica-bility of regulatory limitations prior to use. Users are alsoadvised to refer to Material Safety Data Sheets provided withuncured silicone components.2. Referenced Documents2.1 ASTM Standards:2

9、D1566 Terminology Relating to RubberF813 Practice for Direct Contact Cell Culture Evaluation ofMaterials for Medical Devices2.2 Sterility Standards:3ANSI/AAMI ST41 Good Hospital Practice: Ethylene OxideSterilization and Sterility AssuranceANSI/AAMI ST50 Dry Heat (Heated Air) SterilizersANSI/AAMI ST2

10、9 Recommended Practice for Determin-ing Ethylene Oxide in Medical DevicesANSI/AAM1 ST30 Determining Residual Ethylene Chlo-rohydrin and Ethylene Glycol in Medical DevicesAAMI 13409-251 Sterilization of Health Care ProductsRadiation SterilizationSubstantiation of 25kGy as aSterilization Dose for Smal

11、l or Infrequent ProductionBatchesAAMI TIRS-251 Microbiological Methods for Gamma Ir-radiation Sterilization of Medical Devices2.3 Quality Standards4:ANSI/ASQC Q9001 Quality SystemsModel for QualityAssurance in Design, Development Production, Installa-tion, and Servicing21 CFR 820 Quality System Regu

12、lation (current revision)21 CFR 210 Current Good Manufacturing Practice inManufacturing, Processing, Packing or Holding of Drugs;General (current revision)21 CFR 211 Current Good Manufacturing Practice forFinished Pharmaceuticals (current revision)3. Terminology3.1 Additional pertinent definitions c

13、an be found in Termi-nology D1566.1This specification is under the jurisdiction of ASTM Committee F04 onMedical and Surgical Materials and Devices and is the direct responsibility ofSubcommittee F04.11 on Polymeric Materials.Current edition approved Dec. 1, 2011. Published January 2012. Originallypu

14、blished in 2000. Last previous edition approved in 2005 as F2038 00 (2005).DOI: 10.1520/F2038-00R11.2For referenced ASTM standards, visit the ASTM website, www.astm.org, orcontact ASTM Customer Service at serviceastm.org. For Annual Book of ASTMStandards volume information, refer to the standards Do

15、cument Summary page onthe ASTM website.3Available from American National Standards Institute (ANSI), 25 W. 43rd St.,4th Floor, New York, NY 10036, http:/www.ansi.org.4Available from U.S. Government Printing Office Superintendent of Documents,732 N. Capitol St., NW, Mail Stop: SDE, Washington, DC 204

16、01, http:/www.access.gpo.gov.1Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959, United States.3.2 Definitions:3.2.1 silicone polymerpolymer chains having a backboneconsisting of repeating silicon-oxygen atoms where eachsilicon atom bears two organic

17、groups. The organic groups aretypically methyl, but can be vinyl, phenyl, fluorine, or otherorganic groups.3.2.2 cyclics and linearslow molecular weight volatilecyclic siloxane species are referred to using the “D” nomen-clature which designates the number of Si-O linkages in thematerial (usually D4

18、-D20); species from D7to D40(or more)may be called “macrocyclics”. Linears are straight chainoligomers that may be volatile or of higher molecular weight,depending on chain length; they are designated by “M” and“D” combinations, where “M” is R3Si-O, and D is as explainedabove; “R” is usually methyl.

19、 (For example, MDM is (CH3)3SiOSiOSi(CH3)3). Low molecular weight species are presentin silicone components to varying degrees depending onprocess and storage. The levels of macrocyclics that can beremoved from silicone polymers by vacuum, high temperaturestripping, or oven post-cure is dependent on

20、 the conditionsused.3.2.3 catalysta component of a silicone elastomer formu-lation that initiates the crosslinking reaction when the materialis vulcanized.3.2.4 crosslinker or crosslinking agenta component of asilicone elastomer that is a reactant in the crosslinking reactionthat occurs when an elas

21、tomer is vulcanized.3.2.5 inhibitora component of a silicone elastomer addedto moderate the rate of the crosslinking reaction.3.2.6 fillera finely divided solid that is intimately mixedwith silicone polymers during manufacture to achieve specificproperties. The fillers used in silicone elastomers ar

22、e one oftwo types:3.2.6.1 reinforcing fillersusually have high surface areasand are amorphous in nature such as fumed or precipitatedsilica. Such fillers impart high strength and elastomeric physi-cal properties to the elastomer.3.2.6.2 extending fillerstypically have lower surface areaand lower cos

23、t than reinforcing fillers. They include crystallineforms of silica and diatomaceous earths. While they providesome reinforcement, because they are relatively inexpensive,they are used primarily to extend the bulk of the silicone.3.2.7 additivesa component of a silicone elastomer usedin relatively s

24、mall amounts to perform functions such asmarking, coloring, or providing opacity to the elastomer.3.2.8 silicone basea uniformly blended mixture of sili-cone polymers, fillers, and additives which does not containcrosslinkers or catalyst.3.2.9 uncured elastomera silicone base which containscrosslink

25、er and/or catalyst but has not been vulcanized.3.2.10 silicone elastomeran uncured elastomer that hasbeen subjected to conditions which cause it to become cross-linked. Elastomers may be either high consistency rubbers, lowconsistency rubbers, or RTVs (see below).3.2.10.1 high consistency rubbers (H

26、CRS)are materialswhich cannot be pumped by conventional pumping equipment.They normally must be processed using high shear equipmentsuch as a two-roll mill and parts are typically fabricated usingcompression or transfer molding techniques.3.2.10.2 low consistency rubbers or liquid silicone rubbers(L

27、SRS)are normally flowable materials which can be readilypumped. They can be mixed by pumping through static mixersand parts can be fabricated using injection molding techniques.3.2.10.3 RTVs (room temperature vulcanization) are one-part elastomers which cure in the presence of atmosphericmoisture. L

28、ittle, if any, acceleration of cure rate is realized byincreasing temperature. Because cure is dependent upon diffu-sion of water into the elastomer, cure in depths greater than0.25 in. (0.635 cm) is not recommended.3.2.10.4 gelsare lightly crosslinked materials having noor relatively low levels of

29、reinforcement beyond that providedby the crosslinked polymer. They are usually two-part formu-lations utilizing a platinum catalyzed addition cure system. Thehardness of the gel can be adjusted within wide limits. Thematerial is not usually designed to bear heavy loads but ratherto conform to an irr

30、egular surface providing intimate contact.As a result, loads are distributed over a wider area. Thesematerials may also be used to provide protection from envi-ronmental contaminants.3.2.10.5 foamsare crosslinked materials which have acomponent added to them that generates a volatile gas as themater

31、ial is being vulcanized. This results in a material with avery low density. These are usually two-part formulationsutilizing a platinum catalyzed addition cure system. Theyconform to an irregular surface as they expand to provideintimate contact and protection from the environment but aremore rigid

32、and provide more strength than gels. Since foamsare expanded elastomers, on a weight basis they are highlycrosslinked relative to gels. Most cure conditions will result ina closed cell foam.3.2.11 lot or batcha quantity of material made with afixed, specified formulation in a single, manufacturing r

33、uncarried out under specific processing techniques and condi-tions.3.2.12 vulcanizationan irreversible process in which co-valent chemical bonds are formed between silicone polymerchains. During vulcanization, the material changes from aflowable or moldable compound to an elastomeric materialwhich c

34、annot be reshaped except by its physical destruction.3.2.13 types of curebased upon the cure chemistry em-ployed, silicone elastomers used in medical applications fallinto one of three categories: condensation cure, peroxide cure,and addition cure.3.2.13.1 condensation curethese materials liberate a

35、n or-ganic leaving group during curing and are normally catalyzedby an organometallic compound.one-partmaterial supplied ready to use in an air tightcontainer which cures upon exposure to atmospheric moisture.The material cures from the surface down and cure depths ofgreater than about 0.25 inches (

36、0.635 cm) are not practical.two-partmaterial supplied in two separate containerswhich must be intimately mixed in the prescribed proportionsshortly before use. Because they do not rely upon dispersion ofatmospheric moisture into the silicone, the cure depth is notlimited.F2038 00 (2011)23.2.13.2 per

37、oxide cureone-part formulations vulcanizedby free radicals generated by the decomposition of an organicperoxide.3.2.13.3 addition curetwo-part elastomers which mustfirst be mixed together and then cure by addition of asilylhydride to a vinyl silane in the presence of a platinumcatalyst.3.2.14 disper

38、sionan uncured silicone elastomer dispersedin a suitable solvent to allow application of a thin layer ofelastomer to a substrate by either dipping or spraying.4. Significance and Use4.1 This guide is intended to provide guidance for thespecification and selection of silicone materials for medicaldev

39、ice applications.4.2 Silicone manufacturers supplying materials to the medi-cal device industry should readily provide information regard-ing non-proprietary product formulation to their customerseither directly, or through the US FDA master file program.5. Formulation5.1 Elastomers, gels, and foams

40、 shall be manufactured usingformulations containing combinations of the following rawmaterials.5.1.1 silicone polymerany polymer of medium or highmolecular weight of the structure shown in Fig. 1 where R is amethyl, an unsaturated alkyl group or a hydroxy group, R isgenerally a methyl or an unsatura

41、ted alkyl group but may alsobe a phenyl, trifuoropropyl, or other hydrocarbon radical, andx and y are integers greater than or equal to zero. At least 2.0alkenyl groups must exist per chain if R is not a hydroxy group.5.1.2 catalystan organometallic complex of platinum ortin bonded to ligands made o

42、f any suitable combination ofelements such as carbon, hydrogen, oxygen, fluorine andsilicon.5.1.2.1 platinumthis catalyst may be dispersed in a sili-cone polymer of the structure shown in Fig. 1 having aviscosity low enough that the resulting dispersion is easilypourable. Platinum catalysts can be u

43、sed in the range of 5 to 20ppm of active platinum but typically are present at about 7.5ppm.5.1.2.2 tinone-part condensation cure formulations willtypically contain from 0.1 to 0.5 wt percent of an organotincompound. Two-part condensation cure formulations will typi-cally contain from 0.5 to 2.0 wei

44、ght percent organotin com-pound. The ligands attached to tin will be some combination ofalkyl groups, alkoxy groups, or the anions of a carboxylic acid.5.1.3 Crosslinker or crosslinking agent:5.1.3.1 Two-part, addition cure formulationthe cross-linker is a polymer of the structure shown in Fig. 2 wh

45、ere R isgenerally a methyl or a hydrogen group such as to provide atleast 2.0 SiH groups per chain and x and y are integers greaterthan or equal to zero. In order to avoid chain extension, thefunctionality of either the vinyl-containing polymer or theSiH-containing crosslinker must be at least 3.0.B

46、ecause of the limitless possibilities for the structure of boththe crosslinker and the functional (vinyl containing) polymer, itwould be meaningless to define a weight range for the level ofcrosslinker in a formulation. However, the amount of cross-linker will typically be sufficient to provide a st

47、oichiometricexcess of SiH groups over the amount of unsaturated alkylgroups when the 2 components (parts) of the addition curesilicone elastomer are mixed together in the manufacturersrecommended ratio.5.1.3.2 One-part RTVs and two-part addition cureformulationsthe crosslinker may be an organosilane

48、 mono-mer of the general formula:RxSiOR!42x(1)where:R = organic group excluding phenylOR = hydrolyzable group such as alkoxy, acetoxy, ke-toximo, etc.5.1.3.3 Peroxide vulcanized elastomersorganic peroxidescomprise a third type of crosslinking agent which participatesin the crosslinking reaction that

49、 does not become directlyincorporated into the crosslinked network. Peroxide levelsrange from less than a percent to as high as a couple of weightpercent in the total formulation. These peroxides decompose, ata rate which is dependent upon the temperature, to formradicals which then abstract hydrogen atoms from some of thealkyl groups attached to the silicone backbone. Recombinationof these radicals results in the formation of a crosslinkedsilicone network. One commonly used peroxide is 2,4,-dichlorobenzoyl peroxide. Decomposition of this p